Skip to content

Blueberry Effects on Dark Vision and Glare Recovery

Placebo-controlled Cross-over Studies Examining Blueberries Effects on Dark Vision and Recovery After Photo-bleaching

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01942746
Enrollment
72
Registered
2013-09-16
Start date
2005-07-31
Completion date
2006-07-31
Last updated
2013-09-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Blindness and Low Vision

Keywords

blueberry, anthocyanin, dark vision, photo bleaching, Visual Perception, Photic Stimulation

Brief summary

Clinical evidence for effects of plant anthocyanins on vision, and particularly night vision is controversial. Two clinical trials were conducted to investigate whether blueberry juice consumption affected visual dark adaptation, functional night vision, and recovery after photo-bleaching of the retina. One trial (S2) employed a 3 week intervention and washout period, and two doses of blueberries plus a placebo. The other trial (L1) employed a 12 week intervention plus an 8 week washout and tested one blueberry juice dose against a juice placebo.

Detailed description

Vision Tests: 1. Dark adaptometry, 2. scotopic visual acuity, 3. scotopic contrast sensitivity, 4. rod/cone conversion, 5. recovery after retinal photobleaching

Interventions

DIETARY_SUPPLEMENTBlueberry Juice S2

Blueberry Juice S2 was commercially prepared single strength blueberry juice composed of a 50:50 blend of Rubel (Vaccinium corymbosum L.) and Tifblue (Vaccinium ashei Reade) cultivars. Colorimetric analysis showed that S2 juice contained 6.04 (SD=0.20) mg anthocyanins (C3G) eq/g dry mass.

DIETARY_SUPPLEMENTBlueberry Capsules S2

Commercially prepared single strength blueberry juice composed of a 50:50 blend of Rubel (Vaccinium corymbosum L.) and Tifblue (Vaccinium ashei Reade) cultivars was freeze dried then powdered and encapsulated in gelatin capsules. Colorimetric analysis indicated an anthocyanin concentration in the powder of 2.37(SD=0.18) mg C3G eq per capsule.

DIETARY_SUPPLEMENTPlacebo Capsule S2

Placebo Capsule S2 (containing no anthocyanins) were prepared by freeze drying red beets and grinding them to fine powder before encapsulating in gelatine capsules. Red beets do not contain anthocyanins.

DIETARY_SUPPLEMENTPlacebo Juice L1

Placebo juice was prepared from water, sugars, citric acid, sodium citrate, and artificial colors and flavours, then pasteurized. The placebo juice contains no anthocyanins.

DIETARY_SUPPLEMENTBlueberry Juice L1

Blueberry Juice L1 was commercially prepared single strength blueberry juice composed of a 50:50 blend of Rubel (Vaccinium corymbosum L.) and Tifblue (Vaccinium ashei Reade) cultivars. Colorimetric analysis showed that L1 juice contained 6.83 (SD=0.20) mg cyanidin-3-glucoside equivalents (C3GE)/g dry mass at the start of the study, declining to 5.52 (SD=0.09) mg C3GE/g dry mass after 3 months refrigerated storage.

Sponsors

Dalhousie University
CollaboratorOTHER
U.S. Highbush Blueberry Council
CollaboratorOTHER
Atlantic Food and Horticulture Research Center
Lead SponsorOTHER_GOV

Study design

Allocation
NON_RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
BASIC_SCIENCE
Masking
DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
35 Years to 65 Years
Healthy volunteers
Yes

Inclusion criteria

* visual acuity better than 6/7.5 on EDTRS acuity chart at 2.5m * visual contrast sensitivity within normal range at 2.5m as tested on Visteck 3000 * stereo acuity better than 80 seconds of arc on Frisby stereoacuity test * no ocular history other than refractive glasses * no family history of eye disease

Exclusion criteria

* family history of retinal degeneration, glaucoma, diabetes, hypertension, cataract, or amblyopia (dimness in vision). * evidence in subject (upon examination) of amblyopia (dimness in vision), manifest strabismus (unable to focus both eyes on one spot), or anisotropia (non-uniform responsiveness between both eyes). * intraocular pressure above 21mmHG from an average of three measures using Mentor tonopen-XL

Design outcomes

Primary

MeasureTime frameDescription
Rate of vision adaptation to low light after blueberry juice and placebo ingestion for 3 weeks (S2).Pre-intervention, and changes after 3 weeks of intervention, and again after 3 weeks of washoutEffect of blueberry products and placebo on the rate of vision adaptation to low light. The rate of vision adaptation is measured by lowest perceptible light intensity after 30 min of darkness (dark threshold); time to reach dark threshold (min); time to reach rod/cone transition (min) \[Time Frame: Pre-intervention, after 3 weeks intervention, again after a 3 week washout.\] \[Designated as safety issue: No\]
Rate of vision adaptation to low light after ingestion of blueberry juice and placebo for 12 weeks (L1).Preintervention, and changes after 8 and 12 weeks of intervention and after 4 and 8 weeks of washoutEffect of blueberry products and placebo on the rate of vision adaptation to low light. The rate of vision adaptation is measured by lowest perceptible light intensity after 30 min of darkness (dark threshold); time to reach dark threshold (min); time to reach rod/cone transition (min) \[Time Frame: Pre-intervention, after 8 and 12 weeks intervention, and again after 4 and 8 weeks washout\] \[Designated as safety issue: No\]

Secondary

MeasureTime frameDescription
Rate of recovery of visual acuity after retinal photostress (S2).Pre-intervention testing and testing for changes after 3 weeks of intervention and 3 weeks of washoutAfter dark adaptation testing (primary outcome) and contrast sensitivity and visual acuity testing (other pre-specified outcome measures), participants are subjected to photostress of the retina using bright light. The time (sec) required to recover pre-stress acuity is measured.
Rate of recovery of visual acquity after retinal photostress (L1).Pre-intervention and then testing for changes after 8 and 12 weeks of intervention and 4 and 8 weeks of washout.After dark adaptation testing (primary outcome) and contrast sensitivity and visual acuity testing (other pre-specified outcome measures) participants are subjected to photostress of the retina using bright light. The time (sec) required to recover pre-stress acuity is measured.

Other

MeasureTime frameDescription
Visual acuity and contrast sensitivity testing after dark adaptation (S2).Testing preintervention and testing for changes after 3 weeks of intervention and 3 weeks of washoutAfter dark adaptation testing (primary outcome measure) and before measuring rate of recovery from photo stress (secondary outcome) visual acuity in darkness and contrast sensitivity in darkness was measured using defined optotypes with different degrees of crowding and contrast. Performance was defined as the number of correct answers in 12 tests of acuity and 8 tests of contrast sensitivity.
Visual acuity and contrast sensitivity testing after dark adaptation (L1).Testing preintervention and testing for changes after 8 & 12 weeks of intervention and 4 & 8 weeks of washoutAfter dark adaptation testing (primary outcome measure) and before testing rate of recovery from photo stress (secondary outcome) visual acuity in darkness and contrast sensitivity in darkness was measured using defined optotypes with different degrees of crowding and contrast. Performance was defined as the number of correct answers in 12 tests of acuity and 8 tests of contrast sensitivity.

Countries

Canada

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026